INTRODUCTION
Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare malignant tumor and was described first time in 1998. [1] [2] [3] MIFS usually presents at the extremities. Due to a high propensity for local recurrence and low metastatic rate, MIFS was classified into low-grade malignancy. [4] Differential diagnosis of MIFS is broad and difficult in spite of its distinctive morphology. For accurate diagnosis, the tumor requires extensive clinical, radiological, and pathological investigations. Therefore, wide excision is the first priority for treatment. The efficiency of adjuvant radiotherapy and/or chemotherapy remains controversial. [3, 5, 6] Herein, we report a rare case of MIFS in an elderly patient who developed the lesion at chest wall. To our knowledge, this is the first reported case of MIFS involving the chest wall in Taiwan.
CASE REPORT
An 87-year-old male with a medical history of hypertension presented to our outpatient department (OPD) due to the presence of a huge tumor at his left lateral chest wall. According to the patient's recall, the tumor was movable, rubbery, nontender, and <3 cm in diameter at beginning. During the following 1 year, the tumor developed to more than 15 cm in the greatest diameter that limited the range of motion of the left shoulder joint. In our OPD, the patient exhibited a large palpable mass over the left chest wall and extended to the axilla. The activity and sensation of the left upper limb were normal. Chest computed tomography (CT) scan revealed a huge, heterogeneous mass over the left lateral chest wall and axillary area without adjacent bone destruction [ Figure 1a and b].
The diagnosis after core needle biopsy was a solitary fibrous tumor. Therefore, we performed wide excision of the tumor after circumspect evaluation. The tumor measured 20 cm × 15 cm while the patient was put on right decubitus position in the operation room [ Figure 2a ]. We made an oblique incision just posterior and inferior to the margin of the tumor. The lesion was lobulated with abundant blood supply that was wrapped by clear fibrous boundaries. We performed adhesiolysis carefully by electrocautery and harmonic scalpel to avoid massive bleeding [ Figure 2b ]. We extended the surgical plan to the left axillary area and removed the tumor without muscle or brachial plexus injury [ Figure 2c ]. After achieving hemostasis, we placed two Penrose drains and closed the wound layer by layer. There was no blood transfusion during surgical intervention. The amount of blood loss was about 500 ml.
Microscopically, the sections of specimen showed a lobulated tumor with a thin fibrous capsule and focal infiltrating border. The histological analysis of the specimen revealed alternating myxoid and fibrous areas with mixed inflammatory cells and macrophage infiltration [ Figure 3a ]. The tumor cells were pleomorphic from oval and spindle cells to bizarre epithelioid cells with inclusion-like nucleoli resembling virocytes of Reed-Sternberg cells [ Figure 3b ]. Some vacuolated bizarre cells as lipoblasts were also seen. The tumor cells were positive for CD34, CD68 [ Figure 3c and d], and focally immunoreactive with actin, and negative for CK, S100, and CD30. According to the final pathologic report, the diagnosis became MIFS.
There was no sensory disturbance or dyskinesia after surgical intervention. The patient was discharged on postoperative day 7. Due to a high recurrent rate, the patient underwent adjuvant radiotherapy at surgical bed since postoperative day 40. The amount of dosage was 60 Gy/30 fr. Subsequently, clinical evolution was excellent without complications. Following this, chest CT scan 6 months later revealed disappearance of chest wall lesion without local recurrence.
DISCUSSION
MIFS is a rare, low-grade, malignant soft-tissue tumor that was reported for the first time in 1998 simultaneously by Montgomery et al., [1] Michal, [2] and Meis-Kindblom and Kindblom. [3] In most of the cases, the tumor involves the subcutaneous tissues of the limbs, especially hands and feet. [5] The term "acral" myxoinflammatory fibroblastic sarcoma was dropped in the 2002 World Health Organization classification. MIFS can also develop in other regions such as head and face, gluteal region, and chest wall. [7] [8] [9] Clinically, MIFS usually presents as a slow-growing, solitary, and painless mass. It affects males and females equally in the fifth and sixth decades of life, [1, 3] while approximately 10% of the cases were reported to be under 12 or over 75 years of age. The pathogenesis of MIFS is unknown. Neither CT scan nor magnetic resonance imaging can provide pathognomonic patterns due to mass-varied histological composition.
Histologically, MIFS comprises three characteristics: (a) Multinodular architecture with densely cellular and myxoid hypocellular regions; (b) mixed inflammatory infiltrate; (c) bizarre giant and lipoblast-like cells. According to the immunohistochemistry, vimentin was always strongly positive, CD68 and CD34 exhibited variable positivity, and HMB45 and CD45 were always negative. [3] The differential diagnosis included tenosynovitis, ganglion cyst, myxoma, myxoid malignant fibrous histiocytoma, myxoid liposarcoma, epithelioid sarcoma, giant cell tumor, and solitary fibrous tumor. [10] Due to nonspecific clinical presentation and radiological characteristics, accurate diagnosis is usually delayed until surgical excision.
Due to the high recurrent rate of MIFS (range, 20%-70%), postoperative therapy was needed. Adjuvant radiotherapy may be a proper option for patients who have a large tumor or a positive resection margin. [6] Due to low metastatic rate, adjuvant chemotherapy is controversial. [3] To our knowledge, there were only three other reported cases of chest wall MIFS: Premalata et al. reported upper back MIFS; [7] Narm et al. reported MIFS in the left chest wall; [8] and Jia et al. reported cervicothoracic MIFS with brachial plexus invasion. [9] The present case is the first reported case of chest wall MIFS in Taiwan. Upon literature review and our experience, wider local excision with postoperative radiotherapy seems to be an ideal procedure to deal with MIFS.
CONCLUSION
MIFS is a kind of rare, low-grade, malignant tumor that mainly involves the distal extremities and less commonly occurs in the chest wall. Complete excision should be performed to achieve an accurate diagnosis. We report the first case of MIFS of chest wall in Taiwan. The patient underwent wide excision and postoperative radiotherapy. In addition to surgical resection, long-term follow-up is necessary to detect local recurrence and/or distant metastasis.
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